Ying Cheng

Jilin Cancer Hospital

Changchun

China

SCHOLARLY PAPERS

2

DOWNLOADS

62

SSRN CITATIONS

3

CROSSREF CITATIONS

0

Scholarly Papers (2)

1.

Nivolumab versus Docetaxel in a Predominantly Chinese Patient Population with Previously Treated Advanced Non-Small-Cell Lung Cancer: CheckMate 078 Randomised Phase 3 Clinical Trial

Number of pages: 31 Posted: 25 Sep 2018
Guangdong Academy of Medical Sciences - Guangdong Lung Cancer Institute, Shanghai Jiao Tong University (SJTU), Jilin Cancer Hospital, Tongji University - Department of Medical Oncology, Chinese Academy of Sciences (CAS), The Chinese University of Hong Kong (CUHK), Sun Yat-Sen University (SYSU), Guangdong Academy of Medical Sciences, Central South University - Hunan Cancer Hospital, Jiangsu Cancer Hospital - Department of Medical Oncology, Zhejiang Cancer Hospital, Leningrad Regional Clinical Hospital, Zhejiang University, Zhengzhou University - Henan Cancer Hospital, Sichuan University - West China Hospital, Central South University, Chinese Academy of Medical Sciences - Peking Union Medical College, Bristol-Myers Squibb, Bristol-Myers Squibb and Fudan University
Downloads 52 (411,956)
Citation 2

Abstract:

Loading...

nivolumab; PD-1 inhibitor; non-small-cell lung cancer; NSCLC; China; docetaxel; immunotherapy

2.

Icaritin, a Novel Small-Molecule Immune Modulator in HBV-Related Refractory Advanced Hepatocellular Carcinoma: Safety, Immune Response, Durable Survival and Potential Predictive Biomarkers

Number of pages: 119 Posted: 28 Aug 2019
Nanjing Jinling Hospital, Chinese Academy of Medical Sciences - Cancer Hospital, Government of the People's Republic of China - 307th Hospital, Qingdao University - Affiliated Hospital, Jilin Cancer Hospital, Chinese Academy of Medical Sciences - Cancer Hospital, Shenogen Pharma Group, SinoTech Genomics, Sun Yat-Sen University (SYSU) - School of Life Sciences, Sun Yat-Sen University (SYSU) - School of Life Sciences, Tigermed Consulting Co., Ltd, Chinese Academy of Medical Sciences - Cancer Hospital, Shenogen Pharma Group, SinoTech Genomics and Chinese Academy of Medical Sciences - Cancer Hospital
Downloads 10 (629,106)

Abstract:

Loading...

Icaritin Immune Modulation, Hepatocellular Carcinoma, Durable Survival, Immune Response Biomarkers